FDA Brief

Company record

SpecGx, LLC

0 FDA warning letters since 2023 and 2 recalls in the last 12 months.

Get an email the day FDA posts anything new about SpecGx, LLC.

Recalls

ReportedClassFirmProduct and reason
Jan 14 Class II SpecGx, LLC
Drug
Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01.
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
FDA notice D-0254-2026
Jan 14 Class II SpecGx, LLC
Drug
Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
FDA notice D-0255-2026